Skip to main content
. 2016 Apr 30;214(3):408–416. doi: 10.1093/infdis/jiw173

Figure 1.

Figure 1.

Crude incidence rates of clinical end points across biomarker quartiles. Quartile cut points were defined differently for each study, as described in Supplementary Table 2. Abbreviations: CI, confidence interval; hsCRP, high-sensitivity C-reactive protein; IL-6, interleukin 6; PYFU, person-years of follow-up.